Overexpression [genf]    
CB2 [gngm]    
Improved [qlco]    
Patients [podg]    
HEPATOCELLULAR CARCINOMA [neop]    
CB1 [gngm]    
CB2 [gngm]    
Specific [qlco]    
considered [idcn]    
INHIBITION [menp]    
Tumour NOS [neop]    
Roles [socb]    
Hepatocarcinogenesis [neop]    
Tumour NOS [neop]    
Matched Tissues [bdsu]    
Human [humn]    
HEPATOCELLULAR CARCINOMA [neop]    
Sample [sbst]    
IN SITU HYBRIDIZATION [mbrt]    
Overexpression [genf]    
CB1 [gngm]    
Human [humn]    
HEPATOCELLULAR CARCINOMA [neop]    
Sample [sbst]    
CB2 [gngm]    
Immunohistochemical [lbpr]    
Human [humn]    
HEPATOCELLULAR CARCINOMA [neop]    
Sample [sbst]    
CB1 [gngm]    
normal liver [fndg]    
CHRONIC HEPATITIS [dsyn]    
CIRRHOSIS [dsyn]    
Marked [qlco]    
CB1 [gngm]    
Note [clna]    
majority [socb]    
Cirrhotic [qlco]    
LIVER sample [tisu]    
Human [humn]    
HEPATOCELLULAR CARCINOMA [neop]    
CB1 [gngm]    
Observed [ftcn]    
Cases [ftcn]    
Evaluation [hlca]    
Indicated [fndg]    
Correlation [qlco]    
CB1 [gngm]    
CB2 [gngm]    
Parameters [fndg]    
histopathology [ftcn]    
Differentiation [celf]    
PORTAL VEIN [bpoc]    
Invasion [fndg]    
univariate analysis [resa]    
Indicated [fndg]    
Disease-Free Survival [qnco]    
Human [humn]    
HEPATOCELLULAR CARCINOMA [neop]    
Patients [podg]    
Low [qlco]    
CB1 [gngm]    
CB2 [gngm]    
expression level [qnco]    
0.010" [qnco]    
CB1 [gngm]    
CB2 [gngm]    
Prognostic [inpr]    
Indicators [irda]    
Suggest [idcn]    
Effects [qlco]    
Patients [podg]    
Human [humn]    
HEPATOCELLULAR CARCINOMA [neop]    
rights [qlco]    
Reserve [acty]    
